Financial Partners Group (Kansas)’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,426
Closed -$219K 198
2024
Q4
$219K Sell
2,426
-2
-0.1% -$180 0.03% 172
2024
Q3
$240K Sell
2,428
-208
-8% -$20.6K 0.04% 169
2024
Q2
$244K Sell
2,636
-196
-7% -$18.2K 0.04% 157
2024
Q1
$269K Hold
2,832
0.04% 150
2023
Q4
$253K Buy
+2,832
New +$253K 0.05% 141
2023
Q3
Sell
-2,832
Closed -$230K 175
2023
Q2
$230K Sell
2,832
-586
-17% -$47.6K 0.05% 141
2023
Q1
$260K Hold
3,418
0.06% 135
2022
Q4
$292K Sell
3,418
-592
-15% -$50.6K 0.06% 127
2022
Q3
$318K Sell
4,010
-273
-6% -$21.6K 0.08% 110
2022
Q2
$318K Sell
4,283
-220
-5% -$16.3K 0.08% 107
2022
Q1
$405K Sell
4,503
-572
-11% -$51.4K 0.09% 113
2021
Q4
$474K Sell
5,075
-188
-4% -$17.6K 0.1% 102
2021
Q3
$662K Sell
5,263
-50
-0.9% -$6.29K 0.16% 79
2021
Q2
$719K Sell
5,313
-312
-6% -$42.2K 0.19% 65
2021
Q1
$763K Sell
5,625
-152
-3% -$20.6K 0.22% 58
2020
Q4
$871K Buy
5,777
+1
+0% +$151 0.26% 51
2020
Q3
$644K Buy
5,776
+1
+0% +$111 0.22% 49
2020
Q2
$646K Buy
5,775
+1
+0% +$112 0.25% 44
2020
Q1
$423K Sell
5,774
-31
-0.5% -$2.27K 0.26% 38
2019
Q4
$533K Sell
5,805
-341
-6% -$31.3K 0.21% 47
2019
Q3
$469K Sell
6,146
-204
-3% -$15.6K 0.21% 45
2019
Q2
$557K Sell
6,350
-277
-4% -$24.3K 0.26% 43
2019
Q1
$600K Hold
6,627
0.32% 45
2018
Q4
$476K Sell
6,627
-265
-4% -$19K 0.31% 45
2018
Q3
$661K Hold
6,892
0.43% 40
2018
Q2
$656K Hold
6,892
0.48% 41
2018
Q1
$604K Sell
6,892
-75
-1% -$6.57K 0.47% 43
2017
Q4
$591K Buy
+6,967
New +$591K 0.47% 45